Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues

Oncology Reports

Volumn 16, Issue 4, 2006, Pages 777-780

  Chujo, Masao ^a   Miura, Takashi ^a   Kawano, Yozo ^a   Miyawaki, Michiyo ^a   Imakiire, Takayuki ^a   Hayashita, Yoji ^a   Kawahara, Katsunobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Dihydropyrimidine dehydrogenase; Non small cell lung cancer; Thymidine phosphorylase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; THYMIDINE PHOSPHORYLASE;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; ENZYME IMMUNOASSAY; ENZYMOLOGY; GENE EXPRESSION REGULATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DIHYDROURACIL DEHYDROGENASE (NADP); FLUOROURACIL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; THYMIDINE PHOSPHORYLASE;

EID: 37349005979     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.4.777     Document Type: Article

References (17)

1. Fukukawa T, Yoshimura A, Sumigawa T, et al : Angiogenic factor. Nature 356: 668, 1992.
2. Yano T, Koga T, Ninomiya S and Takeo S: Dihydropyrimidine dehydrogenase levels in non-small-cell lung cancer tissues. Int J Clin Oncol 7: 361-364, 2002. (Pubitemid 36077319)
3. Nakagawa T, Tanaka F, Takata T, et al : Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur + uracil) in patients with p-stage I non-small-cell lung cancer. J Surg Oncol 81: 87-92, 2002.
4. Shintani S, Ohta M, Hirabayashi H, et al: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with nonsmall cell lung cancer. Lung Cancer 45: 189-196, 2004. (Pubitemid 38891481)
5. Murakami N, Hirano M, Saito H, et al : Significance of 5'- deoxy-5-fluorouridine (5'-DFUR) administration before surgery for advanced gastric and colonic cancers-activity of pyrimidine nucleoside phorylase (PyNPase) and serum immunosuppressive acidic protein (IAP) (Eng abstr). Jpn J Cancer Chemother 23: 1959-1966, 1996. (Pubitemid 27044194)
6. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, and Nagasue N: The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 82: 1225-1232, 1998. (Pubitemid 28155382)
7. Mori K, Hasegawa M, Nishida M, et al: Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17: 33-38, 2000.
8. Tsujitani S, Konishi I, Suzuki K, et al: Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients. J Exp Clin Cancer Res 19: 189-195, 2000. (Pubitemid 30490159)
9. Suzuki M, Usui N, Furugen Y and Mitsuhasi N: Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant legions of these organs. Int J Clin Oncol 6: 19-24, 2001. (Pubitemid 32230358)
10. Noguchi T, Moriyama H, Wada S, et al: High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters. Dis Esophagus 16: 307-311, 2003. (Pubitemid 38075589)
11. Anan K, Mitsuyama S, Tamae K, et al: Increased dihydropyrimidine dehydrogenase activity in breast cancer. J Surg Oncol 82: 174-179, 2003. (Pubitemid 36278265)
12. Fujii R, Seshimo A and Kameoka S: Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 8: 72-78, 2003. (Pubitemid 36548474)
13. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T and Ishitsuka H: Preparation of anti-human thymidine phosphorylasemonoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407-1411, 1996. (Pubitemid 26403242)
14. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N and Ishitsuka H: Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidinedehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58: 685-690, 1998. (Pubitemid 28099478)
15. Katsumata K, Sumi T, Yamashita S, et al: The significance of thymidine phosphorylase expression in colorectal cancer. Oncol Rep 8: 127-130, 2001. (Pubitemid 33758214)
16. Kato H, Ichinose Y, Ohta M, et al : A randomized trial of adjuvant chemotherapy with uracil tegafur for adenocarcinoma of the lung. N Engl J Med 350: 1713-1721, 2004. (Pubitemid 38501140)
17. Huang CL, Yokomise H, Kobayashi S, et al : Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU based chemotherapy. Int J Oncol 17: 47-54, 2000.